Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma

Journal of Cellular Biochemistry

Volumn 83, Issue 3, 2001, Pages 364-372

  Baldi, Alfonso ^a   Santini, Daniele ^b   Battista, Tullio ^a   Dragonetti, Emanuele ^c   Ferranti, Giulio ^a   Petitti, Tommasangelo ^d   Groeger, Angela M ^e   Angelini, Anna ^f   Rossiello, Raffaele ^e   Baldi, Feliciano ^a   Natali, Pier Giorgio ^a   Paggi, Marco G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c Diagnostic Center   (Italy)

^d Service of Histopathology IDI   (Italy)

^e UNIVERSITY OF VIENNA   (Austria)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

AP 2; c kit; E cadherin; Human skin melanoma; Immunohistochemistry; p21

Indexed keywords

ONCOPROTEIN; PROTEIN C KIT; PROTEIN P21; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASTIC NEVUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; NEVUS; ONCOGENE C KIT; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR VOLUME; WESTERN BLOTTING;

BLOTTING, WESTERN; CADHERINS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEVUS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034759481     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1235     Document Type: Article

References (31)

1. High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas
2. Molecular mechanisms of melanoma metastasis
3. Role of AP-2 in tumor growth and metastasis of human melanoma
4. The histopathology of cutaneous malignant melanoma
5. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
6. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2
7. Tumor progression and the nature of cancer
8. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
9. Cadherin expression in melanocytic naevi and malignant melanoma
10. WAF1 a potential mediator of p53 tumor suppression
11. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter
12. Mechanisms identified in the transcriptional control of epithelial gene expression
13. Enforced c-kit expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential
14. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
15. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
16. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma
17. Loss of c-kit expression in cultured melanoma cells
18. Expression of IL-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis
19. Malignant melanoma stimulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype
20. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis
21. Progression of human cutaneous melanoma is associated with loss of expression of c-kit protooncogene receptor
22. Molecular pathology of melanoma
23. Cancer statistics
24. Retinoblastoma family genes induce differentiation in neuroblastoma cells and downregulate B-myb promoter
25. Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6
26. P16 and p21/WAF1 protein expression in melanocytic tumors by immunohistochemistry
27. Overexpression of the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma
28. Molecular mechanisms controlling human melanoma progression and metastasis
29. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements
30. A human proto-oncogene c-KIT: A new cell surface receptor tyrosine kinase for an unidentified ligand
31. AP-2 inhibits cancer cell growth and activates p21/WAF/CIP1 expression